Selected research
Industry Research
Automated and Rapid Microbiological Tests Bussiness Industry Research Report 2026
Market perspective
The global Automated and Rapid Microbiological Tests Bussiness market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Automated and Rapid Microbiological Tests Bussiness market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Automated and Rapid Microbiological Tests Bussiness market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Automated and Rapid Microbiological Tests Bussiness market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Automated and Rapid Microbiological Tests Bussiness include Thermo Fisher Scientific, Roche, Siemens Healthcare Diagnostics, Sekisui Diagnostics, Remel, Quidel Corporation, Oxoid Limited, Orion Diagnostica Oy and Orasure Technologies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Automated and Rapid Microbiological Tests Bussiness market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Automated and Rapid Microbiological Tests Bussiness.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Automated and Rapid Microbiological Tests Bussiness Market by Company
Thermo Fisher Scientific
Roche
Siemens Healthcare Diagnostics
Sekisui Diagnostics
Remel
Quidel Corporation
Oxoid Limited
Orion Diagnostica Oy
Orasure Technologies
Meridian Biosciences
MedMira
Gen-Probe
Celsis International
Cellabs
Bio-Rad Laboratories
BioMerieux SA
Becton Dickinson and Company
Abbott Laboratories
Automated and Rapid Microbiological Tests Bussiness Segment by Type
Automated Identification & Susceptibility Systems
Automated Tuberculosis Systems
Automated Blood Culture Systems
Streptococcal Infection Rapid Tests
GC/Chlamydia Rapid Tests
Other
Automated and Rapid Microbiological Tests Bussiness Segment by Application
Clinical
Non-Clinical
Automated and Rapid Microbiological Tests Bussiness Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated and Rapid Microbiological Tests Bussiness market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automated and Rapid Microbiological Tests Bussiness and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated and Rapid Microbiological Tests Bussiness.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Automated and Rapid Microbiological Tests Bussiness companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Automated Identification & Susceptibility Systems
- Automated Tuberculosis Systems
- Automated Blood Culture Systems
- Streptococcal Infection Rapid Tests
- GC/Chlamydia Rapid Tests
- Other
Applications
- Clinical
- Non-Clinical
Companies covered
- Thermo Fisher Scientific
- Roche
- Siemens Healthcare Diagnostics
- Sekisui Diagnostics
- Remel
- Quidel Corporation
- Oxoid Limited
- Orion Diagnostica Oy
- Orasure Technologies
- Meridian Biosciences
- MedMira
- Gen-Probe
- Celsis International
- Cellabs
- Bio-Rad Laboratories
- BioMerieux SA
- Becton Dickinson and Company
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Automated and Rapid Microbiological Tests Bussiness by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Automated Identification & Susceptibility Systems
- 2.2.3 Automated Tuberculosis Systems
- 2.2.4 Automated Blood Culture Systems
- 2.2.5 Streptococcal Infection Rapid Tests
- 2.2.6 GC/Chlamydia Rapid Tests
- 2.2.7 Other
- 2.3 Automated and Rapid Microbiological Tests Bussiness by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical
- 2.3.3 Non-Clinical
- 2.4 Assumptions and Limitations
3 Automated and Rapid Microbiological Tests Bussiness Breakdown Data by Type
- 3.1 Global Automated and Rapid Microbiological Tests Bussiness Historic Market Size by Type (2021-2026)
- 3.2 Global Automated and Rapid Microbiological Tests Bussiness Forecasted Market Size by Type (2027-2032)
4 Automated and Rapid Microbiological Tests Bussiness Breakdown Data by Application
- 4.1 Global Automated and Rapid Microbiological Tests Bussiness Historic Market Size by Application (2021-2026)
- 4.2 Global Automated and Rapid Microbiological Tests Bussiness Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Automated and Rapid Microbiological Tests Bussiness Market Perspective (2021-2032)
- 5.2 Global Automated and Rapid Microbiological Tests Bussiness Growth Trends by Region
- 5.2.1 Global Automated and Rapid Microbiological Tests Bussiness Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Automated and Rapid Microbiological Tests Bussiness Historic Market Size by Region (2021-2026)
- 5.2.3 Automated and Rapid Microbiological Tests Bussiness Forecasted Market Size by Region (2027-2032)
- 5.3 Automated and Rapid Microbiological Tests Bussiness Market Dynamics
- 5.3.1 Automated and Rapid Microbiological Tests Bussiness Industry Trends
- 5.3.2 Automated and Rapid Microbiological Tests Bussiness Market Drivers
- 5.3.3 Automated and Rapid Microbiological Tests Bussiness Market Challenges
- 5.3.4 Automated and Rapid Microbiological Tests Bussiness Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Automated and Rapid Microbiological Tests Bussiness Players by Revenue
- 6.1.1 Global Top Automated and Rapid Microbiological Tests Bussiness Players by Revenue (2021-2026)
- 6.1.2 Global Automated and Rapid Microbiological Tests Bussiness Revenue Market Share by Players (2021-2026)
- 6.2 Global Automated and Rapid Microbiological Tests Bussiness Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Automated and Rapid Microbiological Tests Bussiness Head Office and Area Served
- 6.4 Global Automated and Rapid Microbiological Tests Bussiness Players, Product Type & Application
- 6.5 Global Automated and Rapid Microbiological Tests Bussiness Manufacturers Established Date
- 6.6 Global Automated and Rapid Microbiological Tests Bussiness Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Automated and Rapid Microbiological Tests Bussiness Market Size (2021-2032)
- 7.2 North America Automated and Rapid Microbiological Tests Bussiness Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2021-2026)
- 7.4 North America Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Automated and Rapid Microbiological Tests Bussiness Market Size (2021-2032)
- 8.2 Europe Automated and Rapid Microbiological Tests Bussiness Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2021-2026)
- 8.4 Europe Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Market Size (2021-2032)
- 9.2 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Automated and Rapid Microbiological Tests Bussiness Market Size (2021-2032)
- 10.2 South America Automated and Rapid Microbiological Tests Bussiness Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2021-2026)
- 10.4 South America Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Market Size (2021-2032)
- 11.2 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Roche
- 12.2.1 Roche Company Information
- 12.2.2 Roche Business Overview
- 12.2.3 Roche Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.2.4 Roche Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.2.5 Roche Recent Developments
- 12.3 Siemens Healthcare Diagnostics
- 12.3.1 Siemens Healthcare Diagnostics Company Information
- 12.3.2 Siemens Healthcare Diagnostics Business Overview
- 12.3.3 Siemens Healthcare Diagnostics Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.3.4 Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.3.5 Siemens Healthcare Diagnostics Recent Developments
- 12.4 Sekisui Diagnostics
- 12.4.1 Sekisui Diagnostics Company Information
- 12.4.2 Sekisui Diagnostics Business Overview
- 12.4.3 Sekisui Diagnostics Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.4.4 Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.4.5 Sekisui Diagnostics Recent Developments
- 12.5 Remel
- 12.5.1 Remel Company Information
- 12.5.2 Remel Business Overview
- 12.5.3 Remel Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.5.4 Remel Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.5.5 Remel Recent Developments
- 12.6 Quidel Corporation
- 12.6.1 Quidel Corporation Company Information
- 12.6.2 Quidel Corporation Business Overview
- 12.6.3 Quidel Corporation Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.6.4 Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.6.5 Quidel Corporation Recent Developments
- 12.7 Oxoid Limited
- 12.7.1 Oxoid Limited Company Information
- 12.7.2 Oxoid Limited Business Overview
- 12.7.3 Oxoid Limited Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.7.4 Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.7.5 Oxoid Limited Recent Developments
- 12.8 Orion Diagnostica Oy
- 12.8.1 Orion Diagnostica Oy Company Information
- 12.8.2 Orion Diagnostica Oy Business Overview
- 12.8.3 Orion Diagnostica Oy Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.8.4 Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.8.5 Orion Diagnostica Oy Recent Developments
- 12.9 Orasure Technologies
- 12.9.1 Orasure Technologies Company Information
- 12.9.2 Orasure Technologies Business Overview
- 12.9.3 Orasure Technologies Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.9.4 Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.9.5 Orasure Technologies Recent Developments
- 12.10 Meridian Biosciences
- 12.10.1 Meridian Biosciences Company Information
- 12.10.2 Meridian Biosciences Business Overview
- 12.10.3 Meridian Biosciences Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.10.4 Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.10.5 Meridian Biosciences Recent Developments
- 12.11 MedMira
- 12.11.1 MedMira Company Information
- 12.11.2 MedMira Business Overview
- 12.11.3 MedMira Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.11.4 MedMira Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.11.5 MedMira Recent Developments
- 12.12 Gen-Probe
- 12.12.1 Gen-Probe Company Information
- 12.12.2 Gen-Probe Business Overview
- 12.12.3 Gen-Probe Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.12.4 Gen-Probe Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.12.5 Gen-Probe Recent Developments
- 12.13 Celsis International
- 12.13.1 Celsis International Company Information
- 12.13.2 Celsis International Business Overview
- 12.13.3 Celsis International Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.13.4 Celsis International Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.13.5 Celsis International Recent Developments
- 12.14 Cellabs
- 12.14.1 Cellabs Company Information
- 12.14.2 Cellabs Business Overview
- 12.14.3 Cellabs Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.14.4 Cellabs Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.14.5 Cellabs Recent Developments
- 12.15 Bio-Rad Laboratories
- 12.15.1 Bio-Rad Laboratories Company Information
- 12.15.2 Bio-Rad Laboratories Business Overview
- 12.15.3 Bio-Rad Laboratories Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.15.4 Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.15.5 Bio-Rad Laboratories Recent Developments
- 12.16 BioMerieux SA
- 12.16.1 BioMerieux SA Company Information
- 12.16.2 BioMerieux SA Business Overview
- 12.16.3 BioMerieux SA Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.16.4 BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.16.5 BioMerieux SA Recent Developments
- 12.17 Becton Dickinson and Company
- 12.17.1 Becton Dickinson and Company Company Information
- 12.17.2 Becton Dickinson and Company Business Overview
- 12.17.3 Becton Dickinson and Company Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.17.4 Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.17.5 Becton Dickinson and Company Recent Developments
- 12.18 Abbott Laboratories
- 12.18.1 Abbott Laboratories Company Information
- 12.18.2 Abbott Laboratories Business Overview
- 12.18.3 Abbott Laboratories Revenue in Automated and Rapid Microbiological Tests Bussiness Business (2021-2026)
- 12.18.4 Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 12.18.5 Abbott Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst